RYMEZIO Trademark

Trademark Overview

On Thursday, July 31, 2014, a trademark application was filed for RYMEZIO with the United States Patent and Trademark Office. The USPTO has given the RYMEZIO trademark a serial number of 86353334. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 26, 2018. This trademark is owned by Glaxo Group Limited. The RYMEZIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
rymezio

General Information

Serial Number86353334
Word MarkRYMEZIO
Filing DateThursday, July 31, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 26, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 7, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, March 26, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 26, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, August 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 24, 2017EXTENSION 5 GRANTED
Thursday, August 10, 2017EXTENSION 5 FILED
Monday, August 21, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 21, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 10, 2017TEAS EXTENSION RECEIVED
Wednesday, February 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 6, 2017EXTENSION 4 GRANTED
Monday, February 6, 2017EXTENSION 4 FILED
Monday, February 6, 2017TEAS EXTENSION RECEIVED
Friday, November 4, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 3, 2016EXTENSION 3 GRANTED
Wednesday, August 17, 2016EXTENSION 3 FILED
Monday, October 31, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 11, 2016NOTICE OF REVIVAL - E-MAILED
Monday, October 10, 2016EXTENSION RECEIVED WITH TEAS PETITION
Monday, October 10, 2016PETITION TO REVIVE-GRANTED
Monday, October 10, 2016TEAS PETITION TO REVIVE RECEIVED
Monday, September 19, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 19, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, February 27, 2016EXTENSION 2 GRANTED
Wednesday, January 13, 2016EXTENSION 2 FILED
Friday, February 19, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 13, 2016TEAS EXTENSION RECEIVED
Wednesday, August 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 3, 2015EXTENSION 1 GRANTED
Monday, August 3, 2015EXTENSION 1 FILED
Monday, August 3, 2015TEAS EXTENSION RECEIVED
Tuesday, February 17, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 23, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 23, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 3, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 12, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 10, 2014ASSIGNED TO EXAMINER
Thursday, August 7, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 4, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

rymezio pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological